C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms

Patents for C07D 265 - Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms (11,132)
11/2011
11/16/2011	CN101326169B Glucocorticoid receptor modulators as antiinflammatory agents
11/15/2011	CA2685440C Process for producing benzoxazine derivative and production intermediate thereof
11/10/2011	US20110275784 Asymmetric synthesis of peptides
11/10/2011	US20110275619 Inhibitors of bace1 and methods for treating alzheimer's disease
11/09/2011	EP2384324A1 Process for the preparation of efavirenz
11/08/2011	US8053572 Alkyl-analide producing method
11/08/2011	US8053432 Cyclic hydroxylamine as psychoactive compounds
11/03/2011	WO2011137089A1 Activators of human pyruvate kinase
11/03/2011	WO2011136484A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
11/03/2011	US20110269957 Synthesis of inhibitors of 11beta-hydroxysteroid dehydrogenase type 1
11/03/2011	US20110269955 Method for preparing 2-morpholinoisobornane- 10-thiol and intermediates formed therein
11/03/2011	US20110269650 Multifunctional composition base 1,3-oxazinan-6-ones with corrosion inhibition and heavy organic compounds inhibition and dispersants and obtaining process
11/03/2011	US20110268671 Method of Maintaining Oral Health in Animals
11/02/2011	EP2382207A2 Pi3k/mtor kinase inhibitors
11/02/2011	EP2382197A1 Modulators of cystic fibrosis transmembrane conductance regulator
11/01/2011	US8049007 Preparation of amorolfine
11/01/2011	US8048878 Two cyclic cinnamide compound
11/01/2011	US8048825 Haloalkylsulfonanilide derivatives or salt thereof, herbicide comprising the derivatives as active ingredient, and use of the herbicide
11/01/2011	CA2481261C Cellular accumulation of phosphonate analogs of hiv protease inhibitor compounds
10/2011
10/30/2011	CA2738375A1 Multifunctional composition base 1, 3-oxazinan-6-ones with corrosion inhibition and heavy organic compounds inhibition and dispersants and obtaining process
10/27/2011	WO2011132712A1 Novel hydroxamic acid derivative
10/27/2011	WO2011131316A1 Process for preparing 4-(4-aminophenyl)morpholin-3-one
10/27/2011	US20110263604 Oxidase inhibitors and their use
10/27/2011	US20110263582 Cyclic urea inhibitors of 11 b-hydroxysteroid dehydrogenase 1
10/27/2011	US20110262369 Crystalline, enantiomerically pure salt form of a beta-agonist, and the use thereof as a drug
10/27/2011	DE102010018299A1 Verfahren zur Herstellung von 4-(4-Aminophenyl)-morpholin-3-on Process for the preparation of 4- (4-aminophenyl) -morpholin-3-one
10/26/2011	EP2142504B1 Lactam-substituted dicarboxylic acids and use thereof
10/25/2011	US8044047 5-substituted benzoxazines
10/25/2011	US8044046 Medicaments for the treatment of chronic obstructive pulmonary disease
10/20/2011	WO2011130194A2 Methods for producing viloxazine salts and novel polymorphs thereof
10/20/2011	WO2011072257A3 Amyloid binding agents
10/20/2011	US20110257183 Bis-aryl sulfonamides
10/20/2011	CA2795408A1 Methods for producing viloxazine salts and novel polymorphs thereof
10/19/2011	EP2377850A1 TRPV1 vanilloid receptor antagonists with a bicyclic portion
10/19/2011	EP2376495A2 Compositions of protein receptor tyrosine kinase inhibitors
10/19/2011	EP1923387B1 Acylguanidine derivative or salt thereof
10/19/2011	CN101010307B Synthesis of a benzoxazinone
10/18/2011	CA2579207C Morpholine compound
10/13/2011	US20110251198 Methods for producing viloxazine salts and novel polymorphs thereof
10/13/2011	US20110251196 Modulators of G Protein-Coupled Receptor 88
10/13/2011	US20110251189 Hypoxia targeted compounds for cancer diagnosis and therapy
10/13/2011	US20110251185 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
10/13/2011	US20110251125 Disodium salts, monohydrates, and ethanol solvates for delivering active agents
10/12/2011	EP2373660A2 3,6-disubstituted xanthylium salts as medicaments
10/12/2011	EP2373634A1 Morpholinone compounds as factor ixa inhibitors
10/12/2011	CN102212040A Novel preparation method for chiral 2-hydroxymethyl morpholine compounds
10/11/2011	US8034978 Process for the preparation of an amine
10/11/2011	US8034928 Fluorescence assays with improved sensitivity
10/11/2011	US8034809 Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments
10/11/2011	CA2400482C Bupropion metabolites and methods of their synthesis and use
10/06/2011	WO2011121309A1 Phenyl sulfonyl derivatives and their use as histamine h3 antagonists
10/06/2011	WO2011121068A1 Amino derivatives of cyclohex-2-enone, their preparation and use as antioxidants
10/06/2011	WO2011120604A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion"
10/06/2011	US20110245244 Phenoxy acetic acids as ppar delta activators
10/06/2011	US20110245243 Compounds and compositions as cathepsin s inhibitors
10/06/2011	US20110243865 Melanin production inhibitor
10/06/2011	CA2794773A1 Trpv1 vanilloid receptor antagonists with a bicyclic portion
10/05/2011	EP2371816A1 Aminocyclohexenone, their preparation and use as medicament against oxidative stress
10/05/2011	CN101684083B Guanidinoalkanoylamino substituted tetracycline derivatives
10/04/2011	US8030308 Bicyclic sulfonamide derivatives which are L-CPT 1 inhibitors
09/2011
09/29/2011	WO2011118672A1 Plasma kallikrein inhibitor
09/29/2011	WO2011117254A1 Piperidine amides as modulators of the ghrelin receptor
09/29/2011	US20110237511 EP4 Receptor Agonist, Compositions and Methods Thereof
09/29/2011	US20110236982 Analysis of mass spectral data in the quiet zones
09/29/2011	US20110236887 Modified actinomycin-based nucleic acid stains and methods of their use
09/28/2011	EP2367805A2 Modified actinomycin-based nucleic acid stains and methods of their use
09/28/2011	EP2367804A2 Process for preparing efavirenz polymorph
09/28/2011	CN1915981B 2-oxy-benzoxazinone derivatives for the treatment of obesity
09/28/2011	CN102203213A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011	CN102203076A Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/28/2011	CN102203065A Novel phenyl amide or pyridil amide derivatives and their use as gpbar1 agonists
09/27/2011	US8026231 Aminothiolester compounds, pharmaceutical and cosmetic compositions containing same and uses thereof
09/22/2011	US20110230479 Neurotrophin mimetics and uses thereof
09/22/2011	US20110226610 Synthesis of nitrodibenzylfuran chromophore for photodeprotection of organic molecules
09/21/2011	EP2366696A1 Process for producing 4-aminoquinazolines
09/21/2011	EP2365968A2 Composition and method to modify sperm function and increase male gender ratio in mammals
09/21/2011	CN101283019B Polymer and light-emitting polymer element using the same
09/15/2011	US20110224430 Preparation of methionine or selenomethionine from homoserine via a carbamate intermediate
09/15/2011	US20110224429 Processes of enantioselectively forming an aminoxy compound and an 1,2-oxazine compound
09/15/2011	US20110224114 Morpholine Derivatives as Ashless TBN Sources and Lubricating Oil Compositions Containing Same
09/14/2011	CN1802187B Benzoxazinyl-amidocyclopentyl-heterocyclic modulators of chemokine receptors
09/13/2011	US8017610 Phenylpyrrole derivative
09/13/2011	US8017602 N-(2-(2-(5-hydroxy-3-oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-8-yl)ethylamino)ethyl)-3-(phenethoxy)propanamide derivatives, processes for their preparation, pharmaceutical compositions containing them and their use in therapy
09/09/2011	WO2011107903A1 Highly pure mosapride citrate dihydrate and processes for its preparation
09/08/2011	US20110217654 Latent acids and their use
09/08/2011	US20110217234 Imaging ligands
09/07/2011	CN102177153A Compositions and methods for treating alcohol use disorders, pain and other diseases
09/06/2011	US8013152 Biphenyl compounds useful as muscarinic receptor antagonists
09/06/2011	US8012962 Substituted thiomorpholine derivatives
09/01/2011	WO2011105700A1 Novel organic electroluminescent compounds and organic electroluminescent device using the same
09/01/2011	WO2011104127A1 Latent acids and their use
08/2011
08/31/2011	EP1984345B1 Benzoxazines and related nitrogen-containing heterobicyclic compounds useful as mineralocorticoid receptor modulating agents
08/30/2011	US8008292 Condensed benzamide compounds and inhibitors of vanilloid receptor subtype 1 (VR1) activity
08/25/2011	WO2011103435A2 Methods for forming protected organoboronic acids
08/25/2011	US20110207926 Novel dihydrotriazine derivative
08/25/2011	US20110207739 Novel 1, 2-Disubstituted Amido-anthraquinone Derivatives, Preparation Method and application thereof
08/25/2011	US20110207730 Ion channel modulating compounds and uses thereof
08/25/2011	US20110206661 Trimethoxyphenyl inhibitors of tyrosine kinase
08/24/2011	EP2360160A1 Intermediates and their use for producing benzoxazine derivative
08/24/2011	EP1331922B1 Photo-labile pro-fragrance conjugates

1 ... 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 ... 112